OR Foundation
  • About
    • Oral Reconstruction Foundation
      • Purpose and Mission
      • Foundation Board
      • Scientific Working Group
      • Education Working Group
      • History
      • Career
      • News
  • Granting
    • Requirements
    • Application
  • Publications
    • Grant Publications
    • Consensus Publications
  • Awards
    • Research Award
      • Awards 2018/2019
      • Award 2016/2017
      • Award 2014/2015
      • Award 2012/2013
      • Award 2010/2011
      • Award 2008/2009
    • Poster Competition
      • Competition 2018
      • Competition 2016
      • Competition 2014
      • Competition 2012
  • Education
    • International Symposia
    • Global Symposia
    • National Symposia
    • Curriculum
    • Education Courses
    • Webinars
  • Contact
Select Page

Immunohistochemical characteristics of regenerated bone after surgical therapy of advanced ligature-induced peri-implantitis defects.


Schwarz F, Mihatovic I, Golubovic V, Becker J, Sager M

Clin Oral Invest 2014;18(6):1679-86 (Grant CF30801)

Abstract

Objective:

This study seeks to assess and compare immunohistochemical characteristics of regenerated and pristine bone areas following surgical therapy of advanced peri-implantitis.

Methods:

At ligature-induced peri-implantitis defects, the intrabony component was filled with a natural bone mineral (NBM), and the supracrestal component was treated by either an equine bone block (EB) or implantoplasty. NBM and EB were soak-loaded with rhBMP-2 or sterile saline. Membrane (i.e., native collagen) protected sites were submerged for 12 weeks. Osteocalcin (OC) and transglutaminase 2 (TG2; angiogenesis) antigen reactivity was assessed within the augmented-(AA) and pristine bone (PB) areas at non-exposed sites (n = 39 defects).

Results:

In all groups investigated, mean OC (AA, 0.5 ± 0.4 to 1.9 ± 2.9 %/PB, 1.7 ± 2.6 to 3.5 ± 6.5 %) and TG2 (AA, 0.6 ± 0.5 to 1.3 ± 1.5 %/PB, 0.5 ± 0.5 to 1.6 ± 1.9 %) values within AA did not significantly differ from those values assessed within PB (P > 0.05, respectively).

Conclusion:

AA formed in different treatment groups may not be considered as qualitatively (i.e., OC and TG2) compromised bone.

SOURCE

Latest Research Award Winners

Dr. Yifan Zhang
Quantitative Clinical Adjustment Analysis of Posterior Single Implant Crown in a Chairside Digital Workflow: A Randomized Controlled Trial. Clin Oral Impl Res. 2019;30:1059-1066

Read more

Dr. Hyun-Chang Lim
Tissue integration of zirconia and titanium implants with and without buccal dehiscence defects — A histologic and radiographic preclinical study. Clin Oral Impl Res. 2019;30:660-9

Read more

Dr. Lorenzo Tavelli
Acellular dermal matrix and coronally advanced flap or tunnel technique in the treatment of multiple adjacent gingival recessions. A 12-year follow-up from a randomized clinical trial. J Clin Periodontol. 2019;46:937-48

Read more

Dr. Lukasz Witek
Repair of critical-sized long bone defects using dipyridamole-augmented 3D-printed bioactive ceramic scaffolds. J Orthop Res. 2019;37:2499-507

Read more

Oral Reconstruction Foundation


Margarethenstrasse 38 

4053 Basel
Switzerland

Phone: +41 61 565 41 51
Email: info@orfoundation.org

OR Foundation – U.S. Section

2300 Riverchase Center
Birmingham, AL 35244
USA
Phone: +1 205 986 7989
Email: info.us@orfoundation.org

Newsletter

  • Facebook
  • Twitter
  • RSS

© Oral Reconstruction Foundation 2023 | Imprint | Disclaimer | Privacy | Sitemap | Professional websites Basel